ストックスクリーナーアプリを入手
5.21
0.77%
0.04
アフターアワーズ：
5.21
前日終値:
$5.17
開ける：
$5.25
24時間の取引高:
178.33K
Relative Volume:
0.62
時価総額：
$137.72M
収益：
$50.14M
当期純損益:
$-35.38M
株価収益率:
-3.7214
EPS:
-1.4
ネットキャッシュフロー:
$-39.46M
1週間 パフォーマンス:
-11.39%
1か月 パフォーマンス:
+0.77%
6か月 パフォーマンス:
-40.32%
1年 パフォーマンス:
-46.12%
1日の値動き範囲:
$5.155
$5.31
1週間の範囲:
$5.0327
$5.9898
52週間の値動き範囲:
$4.71
$14.16
Avita Medical Inc Stock (RCEL) Company Profile
RCEL を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
RCEL
Avita Medical Inc
|
5.21 | 155.44M | 50.14M | -35.38M | -39.46M | -1.40 |
|
ABT
Abbott Laboratories
|
124.42 | 229.71B | 43.11B | 13.98B | 6.66B | 7.98 |
|
BSX
Boston Scientific Corp
|
103.78 | 154.35B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
387.32 | 149.60B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
89.70 | 114.97B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
76.56 | 45.92B | 5.54B | 4.18B | 623.10M | 7.00 |
Avita Medical Inc Stock (RCEL) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-12-24 | 開始されました | D. Boral Capital | Buy |
| 2024-04-11 | ダウングレード | BTIG Research | Buy → Neutral |
| 2023-06-27 | 開始されました | Cantor Fitzgerald | Overweight |
| 2021-03-02 | 開始されました | Piper Sandler | Overweight |
| 2020-08-27 | 開始されました | BofA Securities | Buy |
| 2020-04-21 | 開始されました | Oppenheimer | Outperform |
| 2020-03-03 | 開始されました | BTIG Research | Buy |
すべてを表示
Avita Medical Inc (RCEL) 最新ニュース
What analysts say about AVITA Medical Inc. stockFastest return on investment - PrintWeekIndia
What drives AVITA Medical Inc. stock priceBreakthrough capital growth - jammulinksnews.com
Will AVITA Medical Inc. stock benefit from AI tech trendsFree Expert-Led Investment Training - beatles.ru
AVITA Medical Inc. Stock Analysis and ForecastFree Stock Market Real-Time Monitoring - jammulinksnews.com
Is AVITA Medical Inc. a good long term investmentFree Expert Stock Watchlist - jammulinksnews.com
(RCEL) Trading Signals - news.stocktradersdaily.com
why avita medical inc. stock attracts strong analyst attentionPredictable Return Stock Picks - Newser
What makes AVITA Medical Inc. stock price move sharplyFree Real-Time Stock Data - Newser
Why AVITA Medical Inc. stock attracts strong analyst attentionProfessional Stock Screener - Newser
How AVITA Medical Inc. stock performs during market volatilityTop ROI Selections - Newser
When Can We Expect A Profit From AVITA Medical, Inc. (NASDAQ:RCEL)? - simplywall.st
Ask the analyst: Can ASX growth story turn a profit before it’s too late? - Morningstar
Top 3 Health Care Stocks You'll Regret Missing This Quarter - inkl
AVITA Medical's High-Stakes Gamble: Can Break-Even Ambitions Outweigh the Debt? - AInvest
(RCEL) Trading Report - news.stocktradersdaily.com
Translational Regenerative Medicine Market Is Booming So - openPR.com
Cantor Fitzgerald Predicts AVITA Medical FY2026 Earnings - MarketBeat
AVITA Medical (RCEL) Receives Continued 'Buy' Rating from D. Bor - GuruFocus
Millennium Management LLC Makes New $426,000 Investment in AVITA Medical, Inc. (NASDAQ:RCEL) - Defense World
Avita Medical Says Data Show Recell Reduced Length of Hospital Stay for Burn Patients - MarketScreener
AVITA Medical Highlights Largest Real-World Analysis Demonstrati - GuruFocus
AVITA Medical (RCEL) Reports Significant Benefits of RECELL Technology in Burn Treatment | RCEL Stock News - GuruFocus
AVITA Medical Highlights Largest Real-World Analysis Demonstrating Reduced Hospital Stay with RECELL | RCEL Stock News - GuruFocus
AVITA Medical Highlights Largest Real-World Analysis Demonstrating Reduced Hospital Stay with RECELL - The Manila Times
New Data: Revolutionary RECELL Treatment Cuts Hospital Stays by 35%, Saves Hospitals $300M in Burn Care - Stock Titan
Cantor Fitzgerald maintains Avita Medical at Overweight, $19 target By Investing.com - Investing.com Canada
AVITA Medical's (RCEL) Buy Rating Reaffirmed at D. Boral Capital - MarketBeat
AVITA Medical (NASDAQ:RCEL) Given “Buy” Rating at D. Boral Capital - Defense World
AVITA Medical, Inc. (NASDAQ:RCEL) Short Interest Up 23.9% in May - MarketBeat
RCEL: AVITA Medical Maintains Buy Rating with $19 Price Target | RCEL Stock News - GuruFocus
AVITA Medical Announces First Clinical Publication Demonstrating Accelerated Autograft Readiness with Cohealyx™ - The Manila Times
Avita Medical (RCEL) Unveils Promising Results for Cohealyx in Wound Treatment | RCEL Stock News - GuruFocus
AVITA Medical’s Cohealyx shows promise in wound care - Investing.com
AVITA Medical Announces First Clinical Publication Demonstrating Accelerated Autograft Readiness with Cohealyx™ | RCEL Stock News - GuruFocus
AVITA Medical’s Cohealyx shows promise in wound care By Investing.com - Investing.com UK
Breakthrough: New Clinical Data Shows AVITA's Wound Treatment Heals 4x Faster Than Standard Care - Stock Titan
BNP Paribas Financial Markets Takes Position in AVITA Medical, Inc. (NASDAQ:RCEL) - Defense World
Avita Medical Stockholders Approve Key Amendments and Elections - TipRanks
Transcript : AVITA Medical, Inc.Shareholder/Analyst Call - MarketScreener
(RCEL) Investment Report - news.stocktradersdaily.com
AVITA Medical, Inc. (NASDAQ:RCEL) Shares Purchased by Ameriprise Financial Inc. - Defense World
AVITA Medical’s RECELL Platform Recognized for Surgical Innovation in 2025 MedTech Breakthrough Awards - Yahoo Finance
AVITA Medical's RECELL Platform Recognized for Surgical Innovation in 2025 MedTech Breakthrough Awards | RCEL Stock News - GuruFocus
No normal is the new normal - The Globe and Mail
Revolutionary Wound Care Tech RECELL Crowned Best Surgical Innovation: How 30,000 Patients Benefited - Stock Titan
Stocks in play: Fury Gold Mines Limited - The Globe and Mail
Avita Medical Inc (RCEL) 財務データ
収益
当期純利益
現金流量
EPS
1.15%
0.17%
大文字化:
|
ボリューム (24 時間):